CAS: 202821-81-6 - 3-(5-chloro-2-hydroxybenzyl)-5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2(3H)-one
Fórmula:C16H10ClF3N2O3
InChI:InChI=1/C16H10ClF3N2O3/c17-12-5-6-13(23)10(7-12)8-22-15(24)25-14(21-22)9-1-3-11(4-2-9)16(18,19)20/h1-7,23H,8H2
- Sinónimos:
- 1,3,4-Oxadiazol-2(3H)-one, 3-[(5-chloro-2-hydroxyphenyl)methyl]-5-[4-(trifluoromethyl)phenyl]-
- 3-((5-chloro-2-hydroxyphenyl)methyl)-5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2(3H)-one
1,3,4-Oxadiazol-2(3H)-one, 3-[(5-chloro-2-hydroxyphenyl)methyl]-5-[4-(trifluoromethyl)phenyl]-
CAS:202821-81-6
Fórmula:
C16H10ClF3N2O3
Pureza:
%
Forma y color:
Solid
Peso molecular:
370.7104
Ref: AN-AG0028G8
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar | |
100mg | A consultar | |
250mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Mayo de 2024
BMS-191011
CAS:202821-81-6
BMS-191011 (BMS-A) is an activator of large-conductance calcium-activated potassium (BKCa) channels ,effective in stroke models
Fórmula:
C16H10ClF3N2O3
Pureza:
98%
Forma y color:
Solid
Peso molecular:
370.71
Ref: TM-T7512
2mg | 46,00 € | |
5mg | 60,00 € | |
10mg | 90,00 € | |
25mg | 162,00 € | |
50mg | 291,00 € | |
100mg | 435,00 € | |
1ml*10 (DMSO) | 68,00 € |
Entrega estimada en Estados Unidos, el Martes 28 de Mayo de 2024
3-(5-Chloro-2-Hydroxybenzyl)-5-[4-(Trifluoromethyl)Phenyl]-1,3,4-Oxadiazol-2(3H)-One
CAS:202821-81-6
3-(5-Chloro-2-Hydroxybenzyl)-5-[4-(Trifluoromethyl)Phenyl]-1,3,4-Oxadiazol-2(3H)-One is a water soluble drug that inhibits the transfer of proteins from one cell …
Fórmula:
C16H10ClF3N2O3
Pureza:
Min. 95%
Peso molecular:
370.71 g/mol
Ref: 3D-FC101122
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 2 de Julio de 2024